Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between BRAF V600E and Redifferentiation Therapy in Patients With Radioiodine-refractory Papillary Thyroid Cancer

NCT03363347 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT03363347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03363347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between BRAF V600E and Redifferentiation Therapy in Patients With Radioiodine-refractory Papillary Thyroid Cancer
Lead sponsor
Heidelberg University
Phase
Observational
Overall status
Completed
Start date
January 1, 2008
Completion date
December 31, 2014
Enrollment
25 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer